ECO’s FY22 trading update is encouraging in so far as trading in China appears to be normalising. As a result, revenues and margins are tracking in line with revised expectations. As outlined at its recent CMD, ECO has an exciting pipeline of new products in development. Investment is therefore continuing at an accelerated level, which will result in lower EBITDA than previously expected. We update our forecasts accordingly, but continue to see scope for a transformed business as these new produ ....
15 Mar 2022
Short term pain for long term gain
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Short term pain for long term gain
ECO Animal Health Group plc (EAH:LON) | 94.0 0 0.0% | Mkt Cap: 63.7m
- Published:
15 Mar 2022 -
Author:
Chris Glasper -
Pages:
3
ECO’s FY22 trading update is encouraging in so far as trading in China appears to be normalising. As a result, revenues and margins are tracking in line with revised expectations. As outlined at its recent CMD, ECO has an exciting pipeline of new products in development. Investment is therefore continuing at an accelerated level, which will result in lower EBITDA than previously expected. We update our forecasts accordingly, but continue to see scope for a transformed business as these new produ ....